Mitchell Mcleod Pugh & Williams Inc. Sells 1,373 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Mitchell Mcleod Pugh & Williams Inc. cut its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,917 shares of the pharmacy operator’s stock after selling 1,373 shares during the quarter. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Walgreens Boots Alliance were worth $207,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in WBA. EverSource Wealth Advisors LLC raised its stake in Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares during the period. Highlander Capital Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter valued at $26,000. Venturi Wealth Management LLC boosted its position in Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the period. FinTrust Capital Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 2,314.5% in the third quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 1,273 shares during the last quarter. Finally, Rocky Mountain Advisers LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $30,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently commented on WBA shares. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Bank of America decreased their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. TD Cowen lowered their target price on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. UBS Group decreased their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. Finally, SVB Leerink dropped their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a report on Monday, March 18th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Price Performance

WBA stock opened at $18.02 on Tuesday. The company’s 50-day moving average price is $19.93 and its two-hundred day moving average price is $21.72. The firm has a market cap of $15.55 billion, a P/E ratio of -2.57, a P/E/G ratio of 1.10 and a beta of 0.73. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a 12 month low of $17.49 and a 12 month high of $35.36.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. During the same period last year, the firm posted $1.16 earnings per share. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be given a dividend of $0.25 per share. The ex-dividend date is Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 5.55%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.

Insider Activity at Walgreens Boots Alliance

In related news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.